Press Archives
Vsevolod “Seva” Polotsky, MD, has been selected to serve as vice chair for research in the Department of Anesthesiology and Critical Care Medicine at the George Washington University (GW) School of Medicine and Health Sciences and the GW Medical Faculty Associates. Polotsky will also serve as professor of anesthesiology and critical care medicine and of pharmacology and physiology.
The George Washington University Vaccine Research Unit in partnership with Scripps Research, IAVI, Fred Hutchinson Cancer Center (FHCC) and the National Institutes of Health, National Institute of Allergy and Infectious Diseases Vaccine Research Center published the results of their Phase 1 Clinical Trial in Science. The results show critical new insights into their novel vaccine strategy, which involves a stepwise approach to producing antibodies capable of targeting a wide range of HIV variants.
Though antiretroviral therapy has made HIV a manageable disease, people living with HIV often suffer from chronic inflammation. This can put them at an increased risk of developing comorbidities such as cardiovascular disease and neurocognitive dysfunction, impacting the longevity and quality of their lives. Now, a new study in Cell Reports explains why chronic inflammation may be happening and how suppression or even eradication of HIV in the body may not resolve it.
The GW School of Medicine and Health Sciences is recruiting participants for the final stage of a clinical trial to evaluate two Omicron-specific vaccines. The study, known as the COVID-19 Variant Immunologic Landscape (COVAIL) trial, is sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). The George Washington University School of Medicine and Health Sciences has received funding support as an agreement under NIH contract number 75N91019D00024 to Leidos Biomedical Research in Frederick, Maryland.
The George Washington University Institute for Spirituality (GWish) recently announced the recipients of five $100,000 grants in support of demonstration projects to develop and implement interprofessional spiritual care models that can be tested in multiple health settings.
The Rodham Institute, part of the George Washington University (GW) School of Medicine and Health Sciences, has been awarded a $713,000 grant from The Washington Home, a charitable foundation, to launch the Geriatric Career Builders Program (GCBP), the first-ever, multi-employer, registered apprenticeship program for direct care workers in the District of Columbia.
The Atlantic Fellows for Health Equity U.S. + Global, part of the Fitzhugh Mullan Institute for Health Workforce Equity, based at the George Washington University Milken Institute School of Public Health, is proud to announce its 2023 cohort — 20 global leaders dedicated to combating health disparities and promoting equity.
The GW School of Medicine and Health Sciences has been selected to serve as one of 24 participating sites for the Phase 2 clinical trial to evaluate additional COVID-19 booster shots in adults, including multiple vaccines based on viral variants such as Delta and Omicron. The trial aims to understand if different vaccine regimens – prototype and variant vaccines alone and in combinations – can broaden immune responses in adults who already have received a primary vaccination series and a first booster shot.
